Former Eli Lilly Exec Expected to be Named Trump's HHS Secretary
President Donald Trump could be close to naming former Eli Lilly exec Alex Azar as new Secretary of HHS, according to reports. Source: BioSpace
How GlaxoSmithKline Lost Nearly $10B in October
Could GlaxoSmithKline's industry-leading dividend be at risk? Source: BioSpace
Sunovion Announces FDA Acceptance for Review of New Drug Application for Dasotraline for the Trea…
The NDA submission is supported by multiple placebo-controlled safety and efficacy studies, as well as two long-term studies that assessed the safety of dasotraline in people with ADHD for up…
Siemens to Replace Healthineers CFO in Preparation for Listing
The public listing that is expected to value the business at around $46 billion. Source: BioSpace
This is the Average Interview Process Time for a Biopharma Job
How long does it take to go from application to job offer at a typical life sciences company? Source: BioSpace
Bay Area's Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi
Sanofi will write a check for $40 million upfront. Source: BioSpace
GlaxoSmithKline's Pain in China is AstraZeneca's Gain
China revenue in Q3 increased by 12 percent at AstraZeneca and the country now accounts for 15 percent of its global product sales. Source: BioSpace
Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression
The positive results support the company's planned regulatory submissions. Source: BioSpace
GlaxoSmithKline Poaches New CSO From Google's Calico
Dr Barron was Executive VP, Head of Global Product Development, and CMO of Roche, responsible for all the products in the combined portfolio of Roche and Genentech. Source: BioSpace
Recipharm to End Operations at Two Swedish Facilities, 225 Employees Affected
The company will explore opportunity to close facilities during second half of 2019. Source: BioSpace
- Go to the previous page
- 1
- …
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- …
- 288
- Go to the next page